TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 52 filers reported holding TALARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,121 | +71.6% | 8,575 | -6.9% | 0.00% | – |
| Q4 2022 | $9,392 | -60.9% | 9,208 | +1.1% | 0.00% | – |
| Q3 2022 | $24,000 | -44.2% | 9,104 | -5.1% | 0.00% | – |
| Q2 2022 | $43,000 | -52.2% | 9,589 | +5.2% | 0.00% | – |
| Q1 2022 | $90,000 | -49.4% | 9,112 | -21.8% | 0.00% | – |
| Q4 2021 | $178,000 | +178.1% | 11,659 | +145.3% | 0.00% | – |
| Q3 2021 | $64,000 | -64.6% | 4,752 | -61.4% | 0.00% | – |
| Q2 2021 | $181,000 | – | 12,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |